ABS0046 The evolving role of Janus Kinase inhibitors (JAKi) in rheumatic and musculoskeletal diseases (RMDs): An international Delphi study
(2025)
Presentation / Conference Contribution
Background:
Janus Kinase inhibitors (JAKi) have become an established therapeutic option for managing various immune mediated inflammatory conditions, including rheumatic and musculoskeletal diseases (RMDs). Greater treatment experience for establis...
Read More about ABS0046 The evolving role of Janus Kinase inhibitors (JAKi) in rheumatic and musculoskeletal diseases (RMDs): An international Delphi study.